Marshall Wace LLP Raises Stake in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)
Marshall Wace LLP lifted its position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 128.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 98,027 shares of the biotechnology company’s stock after purchasing an additional 55,130 shares during […]
